US6818209B1
(en)
*
|
1998-05-22 |
2004-11-16 |
Oxford Biomedica (Uk) Limited |
Retroviral delivery system
|
US20070213290A1
(en)
*
|
1996-10-17 |
2007-09-13 |
Kingsman Alan J |
Neurite regeneration
|
US20040076613A1
(en)
*
|
2000-11-03 |
2004-04-22 |
Nicholas Mazarakis |
Vector system
|
US7635687B2
(en)
*
|
1997-06-04 |
2009-12-22 |
Oxford Biomedica (Uk) Limited |
Vector system
|
ATE298371T1
(de)
*
|
1997-09-24 |
2005-07-15 |
Univ California |
Nicht-primaten lentivirale vektoren und verpackungssysteme
|
GB2356200B
(en)
*
|
1997-12-22 |
2002-05-01 |
Oxford Biomedica Ltd |
Retroviral vectors
|
EP1042493A1
(en)
*
|
1997-12-22 |
2000-10-11 |
Oxford Biomedica (UK) Limited |
Equine infectious anaemia virus (eiav) based retroviral vectors
|
GB9803351D0
(en)
*
|
1998-02-17 |
1998-04-15 |
Oxford Biomedica Ltd |
Anti-viral vectors
|
US6790657B1
(en)
|
1999-01-07 |
2004-09-14 |
The United States Of America As Represented By The Department Of Health And Human Services |
Lentivirus vector system
|
WO2000040741A2
(en)
*
|
1999-01-07 |
2000-07-13 |
The Government Of The United States Of America, As Represented By The Secretary Department Of Health And Human Services, The National Institutes Of Health |
Lentivirus vector system
|
AU3893000A
(en)
*
|
1999-03-16 |
2000-10-04 |
Dana-Farber Cancer Institute, Inc. |
Lentiviral vector system for high quantity screening
|
CN1173036C
(zh)
*
|
1999-04-21 |
2004-10-27 |
卫生部艾滋病预防与控制中心 |
马传染性贫血病毒驴白细胞弱毒疫苗株的全长基因序列
|
DE60038971D1
(de)
|
1999-10-22 |
2008-07-03 |
Aventis Pasteur |
Verfahren zur erregung und/oder verstärkung der immunantwort gegen tumorantigene
|
CN1321182C
(zh)
*
|
1999-12-30 |
2007-06-13 |
卫生部艾滋病预防与控制中心 |
马传染性贫血病毒代表毒株的全基因克隆及其应用
|
GB0009760D0
(en)
*
|
2000-04-19 |
2000-06-07 |
Oxford Biomedica Ltd |
Method
|
EP1282702B1
(en)
*
|
2000-05-10 |
2006-11-29 |
Sanofi Pasteur Limited |
Immunogenic polypeptides encoded by mage minigenes and uses thereof
|
AU8710301A
(en)
*
|
2000-09-09 |
2002-03-22 |
Akzo Nobel Nv |
Eiav chimeric vaccine and diagnostic
|
GB0024550D0
(xx)
*
|
2000-10-06 |
2000-11-22 |
Oxford Biomedica Ltd |
|
US7575924B2
(en)
|
2000-11-13 |
2009-08-18 |
Research Development Foundation |
Methods and compositions relating to improved lentiviral vectors and their applications
|
WO2002079482A2
(en)
*
|
2000-11-16 |
2002-10-10 |
Rigel Pharmaceuticals, Inc. |
In vitro transcribed retroviral genomes, methods for their production and methods of use
|
US6712612B1
(en)
|
2000-12-12 |
2004-03-30 |
Genecure Llc |
Safe and stable retroviral helper cell line and related compositions and methods
|
EP1373536B9
(en)
*
|
2001-03-13 |
2009-09-02 |
Novartis AG |
Lentiviral packaging constructs
|
US7211247B2
(en)
|
2001-04-09 |
2007-05-01 |
University Of Southern California |
Lentivirus vectors for gene transfer to alveolar epithelial cells
|
CA2344208A1
(en)
|
2001-04-30 |
2002-10-30 |
Oxford Biomedica (Uk) Limited |
Method
|
ATE527347T1
(de)
|
2001-08-02 |
2011-10-15 |
Inst Clayton De La Rech |
Verfahren und zusammensetzungen im zusammenhang mit verbesserten lentivirusvektor- produktionssystemen
|
IL161229A0
(en)
*
|
2001-10-02 |
2004-09-27 |
Inst Clayton De La Rech |
Methods and compositions relating to restricted expression lentiviral vectors and their applications.
|
CA2468861C
(en)
|
2001-12-05 |
2012-06-12 |
The Regents Of The University Of California |
Robotic microscopy systems
|
EP1864691B1
(en)
|
2002-04-09 |
2011-07-20 |
Sanofi Pasteur Limited |
Modified CEA nucleic acid and expression vectors
|
CN100340668C
(zh)
*
|
2002-04-26 |
2007-10-03 |
国家健康医学研究所 |
改进的嵌合糖蛋白和假型化慢病毒载体
|
AU2003291426A1
(en)
*
|
2002-11-12 |
2004-06-03 |
The Government Of The United States Of America, As Represented By The Secretary, Department Of Health Human Services, The National Institutes Of Health |
Gp64-pseudotyped vectors and uses thereof
|
WO2004048583A2
(en)
*
|
2002-11-22 |
2004-06-10 |
Institut Clayton De La Recherche |
Compositions and systems for the regulation of genes
|
CA2511521C
(en)
|
2002-12-30 |
2012-02-07 |
Angiotech International Ag |
Drug delivery from rapid gelling polymer composition
|
US8026819B2
(en)
*
|
2005-10-02 |
2011-09-27 |
Visible Assets, Inc. |
Radio tag and system
|
AU2004269233A1
(en)
*
|
2003-08-29 |
2005-03-10 |
Kaneka Corporation |
Method of constructing transgenic bird using lentivirus vector and transgenic bird obtained thereby
|
CA2550583C
(en)
*
|
2003-10-08 |
2013-01-15 |
Sanofi Pasteur, Inc. |
Modified cea /b7 vector
|
AU2005327198B2
(en)
*
|
2004-07-09 |
2011-03-31 |
University Of North Carolina At Chapel Hill |
Viral adjuvants
|
AU2006302794B2
(en)
*
|
2005-02-15 |
2011-08-04 |
Children's Hospital, Inc. |
New live virus vaccines
|
WO2007089780A2
(en)
*
|
2006-01-30 |
2007-08-09 |
Licentia, Ltd. |
Bmx/etk tyrosine kinase gene therapy materials and methods
|
US8105575B2
(en)
*
|
2006-10-10 |
2012-01-31 |
Viromed Co., Ltd. |
Expression vectors with improved safety
|
EP2089513A1
(en)
|
2006-12-07 |
2009-08-19 |
Publiekrechtelijke rechtspersoon Academisch Ziekenhuis Leiden h.o.d.n. Leids Universitair Medisch Centrum |
Use of a varicellovirus tap-inhibitor for the induction of tumor- or virus-specific immunity against teipp
|
CN101705246B
(zh)
*
|
2007-04-29 |
2012-06-27 |
中国农业科学院哈尔滨兽医研究所 |
慢病毒基因转移载体、其制备方法和应用
|
US9593340B2
(en)
|
2007-10-15 |
2017-03-14 |
Admedus Vaccines Pty Ltd. |
Expression system for modulating an immune response
|
CA2705862C
(en)
|
2007-11-16 |
2018-03-27 |
San Diego State University Research Foundation |
Compositions and method for manipulating pim-1 activity in circulatory system cells
|
WO2010087702A1
(en)
|
2009-01-30 |
2010-08-05 |
Stichting Katholieke Universiteit |
TET2 gene as a marker for diagnosing a myelodysuplastic syndrome (MDS) or an acute myeloid leukemia (AML) and determining the prognosis in a subject
|
US9752124B2
(en)
|
2009-02-03 |
2017-09-05 |
Koninklijke Nederlandse Akademie Van Wetenschappen |
Culture medium for epithelial stem cells and organoids comprising the stem cells
|
EP3441458B9
(en)
|
2009-02-03 |
2023-08-23 |
Koninklijke Nederlandse Akademie van Wetenschappen |
Culture medium for epithelial stem cells and organoids comprising said stem cells
|
EP2412800A1
(en)
|
2010-07-29 |
2012-02-01 |
Koninklijke Nederlandse Akademie van Wetenschappen |
Liver organoid, uses thereof and culture method for obtaining them
|
CN101532031B
(zh)
*
|
2009-03-03 |
2011-04-20 |
上海吉盛制药技术有限公司 |
非整合慢病毒载体系统及其制备与应用
|
WO2011034421A1
(en)
|
2009-09-16 |
2011-03-24 |
Stichting Het Nederlands Kanker Instituut |
Fra-1 target genes as drug targets for treating cancer
|
EP2305717A1
(en)
|
2009-09-21 |
2011-04-06 |
Koninklijke Nederlandse Akademie van Wetenschappen |
Inhibiting TNIK for treating colon cancer
|
EP2319918B1
(en)
*
|
2009-11-10 |
2013-01-16 |
Centre National De La Recherche Scientifique |
Lentiviral-based vector and its use in directed evolution of genomic regions, genes and polynucleotides
|
WO2011066578A1
(en)
*
|
2009-11-30 |
2011-06-03 |
American Gene Technologies International Inc. |
Safe lentiviral vectors for targeted delivery of multiple therapeutic molecules to treat liver cancer
|
US9795658B2
(en)
|
2010-04-20 |
2017-10-24 |
Admedus Vaccines Pty Ltd |
Expression system for modulating an immune response
|
WO2012007458A1
(en)
|
2010-07-12 |
2012-01-19 |
Universidad Autónoma De Barcelona |
Gene therapy composition for use in diabetes treatment
|
WO2012047093A1
(en)
|
2010-10-05 |
2012-04-12 |
Academisch Ziekenhuis Bij De Universiteit Van Amsterdam |
Treatment of the sjögren's syndrome
|
EP2465928A1
(en)
|
2010-12-16 |
2012-06-20 |
Academisch Medisch Centrum bij de Universiteit van Amsterdam |
Treatment of Th17-mediated diseases
|
AU2012216792A1
(en)
|
2011-09-12 |
2013-03-28 |
International Aids Vaccine Initiative |
Immunoselection of recombinant vesicular stomatitis virus expressing HIV-1 proteins by broadly neutralizing antibodies
|
EP2586461A1
(en)
|
2011-10-27 |
2013-05-01 |
Christopher L. Parks |
Viral particles derived from an enveloped virus
|
US9347065B2
(en)
|
2012-03-29 |
2016-05-24 |
International Aids Vaccine Initiative |
Methods to improve vector expression and genetic stability
|
AU2013281328B2
(en)
|
2012-06-27 |
2017-11-23 |
Meiragtx Uk Ii Limited |
Combination for treating an inflammatory disorder
|
DK3103872T3
(en)
|
2012-07-12 |
2018-10-22 |
Proqr Therapeutics Ii Bv |
OLIGONUCLEOTIDES TO MAKE A CHANGE IN THE SEQUENCE OF A TARGET RNA MOLECULE IN A LIVING CELL
|
EP2692868A1
(en)
|
2012-08-02 |
2014-02-05 |
Universitat Autònoma De Barcelona |
Adeno-associated viral (AAV) vectors useful for transducing adipose tissue
|
US9730996B2
(en)
|
2012-10-24 |
2017-08-15 |
Texas Biomedical Research Institute |
Involucrin-driven retroviral expression cassettes encoding human immunodeficiency virus envelope glycoproteins
|
TW201522637A
(zh)
|
2013-03-15 |
2015-06-16 |
Jackson Lab |
非胚胎幹細胞之單離及其用途
|
WO2015069469A1
(en)
|
2013-11-05 |
2015-05-14 |
Clontech Laboratories, Inc. |
Dry transfection compositions and methods for making and using the same
|
AU2015247727A1
(en)
|
2014-04-15 |
2016-11-03 |
University Of Virginia Patent Foundation |
Isolated T cell receptors and methods of use therefor
|
EP3031923A1
(en)
*
|
2014-12-11 |
2016-06-15 |
Institut Pasteur |
Lentiviral vector-based japanese encephalitis immunogenic composition
|
EP3242945B1
(en)
|
2015-01-07 |
2021-09-01 |
Universitat Autònoma de Barcelona |
Single-vector gene construct comprising insulin and glucokinase genes
|
CN108883105B
(zh)
|
2015-10-23 |
2022-07-15 |
杰克逊实验室 |
烟酰胺用于治疗和预防眼部神经退行性疾病如青光眼
|
US10711282B2
(en)
|
2015-11-23 |
2020-07-14 |
Novartis Ag |
Optimized lentiviral transfer vectors and uses thereof
|
CA3006779A1
(en)
|
2015-12-09 |
2017-06-15 |
Admedus Vaccines Pty Ltd |
Immunomodulating composition for treatment
|
EP4099015A1
(en)
|
2016-06-10 |
2022-12-07 |
Gadeta B.V. |
Novel method for identifying deltat-cell (or gammat-cell) receptor chains or parts thereof that mediate an anti-tumour or an anti-infective response
|
US11285191B2
(en)
|
2016-07-26 |
2022-03-29 |
The Board Of Supervisors Of Louisiana State University And Agricultural And Mechanical College |
Immunostimulatory compositions and uses therefor
|
US20190367944A1
(en)
|
2017-01-30 |
2019-12-05 |
The U.S.A., As Represented By The Secretary, Department Of Health And Human Services |
Recombinant virus vectors for the treatment of glycogen storage disease
|
JP2020530977A
(ja)
|
2017-05-24 |
2020-11-05 |
ウニベルシダッド アウトノマ デ バルセロナ |
線維芽細胞増殖因子21(fgf21)コーディング配列を含むウイルス発現コンストラクト
|
EP3648776A4
(en)
|
2017-07-06 |
2021-04-07 |
The Medical College of Wisconsin, Inc. |
NEW IN VITRO AND IN VIVO ENRICHMENT STRATEGY TARGETING CHS-DERIVED LYMPHOCYTES TRANSDUCED BY A VECTOR FOR THE THERAPY OF DISORDERS
|
CA3086765A1
(en)
|
2017-12-28 |
2019-07-04 |
Tract Pharmaceuticals, Inc. |
Stem cell culture systems for columnar epithelial stem cells, and uses related thereto
|
WO2019219979A1
(en)
|
2018-05-18 |
2019-11-21 |
Umc Utrecht Holding B.V. |
Compositions and methods for cell targeting therapies
|
US20220275043A1
(en)
|
2018-07-17 |
2022-09-01 |
Massachusetts Institute Of Technology |
Soluble multimeric immunoglobulin-scaffold based fusion proteins and uses thereof
|
CA3120923A1
(en)
|
2018-11-26 |
2020-06-04 |
Universitat Autonoma De Barcelona |
Fibroblast growth factor 21 (fgf21) gene therapy
|
CA3120576A1
(en)
|
2018-11-26 |
2020-06-04 |
Massachusetts Institute Of Technology |
Compositions and methods for immune tolerance
|
CA3140507A1
(en)
|
2019-05-31 |
2020-12-03 |
Universitat Autonoma De Barcelona |
Insulin gene therapy
|
JP2023515711A
(ja)
|
2020-04-27 |
2023-04-13 |
ユニヴァーシティ オブ アイオワ リサーチ ファウンデーション |
組成物および嚢胞性線維症の処置のための方法
|
IL298532A
(en)
|
2020-05-26 |
2023-01-01 |
Univ Barcelona Autonoma |
Gene therapy for diseases related to the central nervous system using fibroblast growth factor 21 (fgf21)
|
WO2021242719A1
(en)
*
|
2020-05-27 |
2021-12-02 |
The Medical College Of Wisconsin, Inc. |
Improved lentiviral vector transfer plasmid and methods of use
|
JP2023552531A
(ja)
|
2020-12-10 |
2023-12-18 |
サレプタ セラピューティクス, インコーポレイテッド |
接着細胞のための懸濁モードシードトレイン開発
|
WO2022162067A1
(en)
|
2021-01-30 |
2022-08-04 |
Universitat Autònoma De Barcelona |
Gene therapy for monogenic diabetes
|
WO2022221462A1
(en)
|
2021-04-13 |
2022-10-20 |
Kriya Therapeutics, Inc. |
Vector constructs for delivery of nucleic acids encoding therapeutic vlcad or mcad and methods of using the same
|
EP4089171A1
(en)
|
2021-05-12 |
2022-11-16 |
Fundación del Sector Público Estatal Centro Nacional de Investigaciones Oncológicas Carlos III (F.S.P. CNIO) |
Recombinant tert-encoding viral genomes and vectors
|
WO2022258606A1
(en)
|
2021-06-07 |
2022-12-15 |
Gadeta B.V. |
Delta T-cell or Gamma T-cell receptor chains or parts thereof that mediate an anti-tumour or anti-infective response
|
WO2023285700A1
(en)
|
2021-07-16 |
2023-01-19 |
Academisch Ziekenhuis Leiden H.O.D.N. Lumc |
Oligonucleotide for inhibiting quaking activity
|
WO2023212683A1
(en)
|
2022-04-29 |
2023-11-02 |
Kriya Therapeutics, Inc. |
Insulin and glucokinase gene therapy compositions and its use for treating diabetes
|
WO2023227594A1
(en)
|
2022-05-24 |
2023-11-30 |
Gadeta Bv |
Novel deltat-cell receptor chains, gammat-cell receptor chains, or parts thereof
|
WO2023237541A1
(en)
|
2022-06-07 |
2023-12-14 |
Gadeta B.V. |
Delta t-cell or gamma t-cell receptor chains or parts thereof that mediate an anti-tumour or anti-infective response
|
US20240075068A1
(en)
|
2022-07-15 |
2024-03-07 |
Gadeta B.V. |
Novel soluble gamma T-cell (or soluble delta T-cell) receptor chains (or soluble gammadelta T-cell receptors) or fragments thereof that mediate an anti-tumour or an anti-infective response
|
WO2024052413A1
(en)
|
2022-09-07 |
2024-03-14 |
Universitat Autònoma De Barcelona |
Beta-hexosaminidase vectors
|
WO2024100136A1
(en)
|
2022-11-08 |
2024-05-16 |
Gadeta B.V. |
Novel method for obtaining gamma t-cell (or delta t-cell) receptor chains (or gamma delta t-cell receptors) or fragments thereof that mediate an anti-tumour or an anti-infective response
|